Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brodfuehrer

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Pharmaceutical Research|November 6, 2013
Quantitative analysis of target coverage and germinal center response by a CXCL13 neutralizing antibody in a T-dependent mouse immunization modelJoanne Brodfuehrer, Andrew Rankin, Jason Edmonds, et al.
Journal of Medicinal Chemistry|April 2, 2005
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6Peter L Toogood, Patricia J Harvey, Joseph T Repine, et al.
Journal of Medicinal Chemistry|June 29, 2001
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parametersS E Hagen, J Domagala, C Gajda, et al.
European Journal of Medicinal Chemistry|January 20, 2018
Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitorsFrank Lovering, Paul Morgan, Christophe Allais, et al.
Annual Review of Chemical and Biomolecular Engineering|April 8, 2020
Water Treatment: Are Membranes the Panacea?Matthew R Landsman, Rahul Sujanani, Samuel H Brodfuehrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2024
Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparinMarc Douaisi, Elena E Paskaleva, Li Fu, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2021
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical TrialAaron Winkler, Weiyong Sun, Saurav De, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Pharmaceutical Research|November 6, 2013
Quantitative analysis of target coverage and germinal center response by a CXCL13 neutralizing antibody in a T-dependent mouse immunization modelJoanne Brodfuehrer, Andrew Rankin, Jason Edmonds, et al.
Journal of Medicinal Chemistry|April 2, 2005
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6Peter L Toogood, Patricia J Harvey, Joseph T Repine, et al.
Journal of Medicinal Chemistry|June 29, 2001
4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parametersS E Hagen, J Domagala, C Gajda, et al.
European Journal of Medicinal Chemistry|January 20, 2018
Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitorsFrank Lovering, Paul Morgan, Christophe Allais, et al.
Annual Review of Chemical and Biomolecular Engineering|April 8, 2020
Water Treatment: Are Membranes the Panacea?Matthew R Landsman, Rahul Sujanani, Samuel H Brodfuehrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2024
Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparinMarc Douaisi, Elena E Paskaleva, Li Fu, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Nonpeptidic HIV protease inhibitors: 6-alkyl-5,6-dihydropyran-2-ones possessing achiral 3-(4-amino/carboxamide-2-t-butyl,5-methylphenyl thio) moiety: antiviral activities and pharmacokinetic propertiesJ V Vara Prasad, F E Boyer, J M Domagala, et al.
Journal of Medicinal Chemistry|March 15, 2000
5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV proteaseF E Boyer, J V Vara Prasad, J M Domagala, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 23, 2021
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical TrialAaron Winkler, Weiyong Sun, Saurav De, et al.
Journal of Medicinal Chemistry|November 9, 2007
Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-Fluoro-4- (1-oxotetrahydrothiopyran-4-yl)phenyl]-2- oxooxazolidine-5-carboxylic acid amide (PF-00422602), a new lead compoundToni-Jo Poel, Richard C Thomas, Wade J Adams, et al.
Pageof 8